DNA Pharmaceutical Formulations Comprising Citrate or Triethanolamine and Combinations Thereof

Details for Australian Patent Application No. 2003203737 (hide)

Owner Merck & Co., Inc.

Inventors Evans, Robert K.; Xu, Zheng; Bruner, Mark W.; Volkin, David B.

Agent Spruson & Ferguson

Pub. Number AU-B-2003203737

Parent 19405

Filing date 17 April 2003

Wipo publication date 12 June 2003

Acceptance publication date 22 June 2006

International Classifications

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

8 May 2003 Complete Application Filed

12 June 2003 Application Open to Public Inspection

  Published as AU-B-2003203737

22 June 2006 Application Accepted

  Published as AU-B-2003203737

26 October 2006 Standard Patent Sealed

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003203738-Apparatus for Loading Bottom-loading Basket-style Carrier

2003203736-Automatic mailing machine and method of handling postal items